Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Fortrea Holdings Inc. (FTRE : NSDQ)

• Company Description    Fortrea Holdings Inc. is a provider of clinical development and patient access solutions to the life sciences industry. It provides phase I-IV clinical trial management, clinical pharmacology, differentiated technology enabled trial solutions and post-approval services. Fortrea Holdings Inc. is based in DURHAM, N.C. Number of Employees: 15,500

• Price / Volume Information    Yesterday's Closing Price: $9.79 Daily Weekly Monthly 20 Day Moving Average: 1,576,547 shares Shares Outstanding: 92.40 (millions) Market Capitalization: $904.60 (millions) Beta: 1.59 52 Week High: $18.67 52 Week Low: $3.97 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -40.67% -39.76% 12 Week -10.18% -13.25% Year To Date -43.25% -43.17%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 8 MOORE DRIVE - DURHAM,NC 27709 USA ph: 877-495-0816 fax: - investors@fortrea.com http://www.fortrea.com

• General Corporate Information    Officers Thomas Pike - Chief Executive Officer;President and Chairman Jill McConnell - Chief Financial Officer Robert Parks - Chief Accounting Officer Peter M. Neupert - Director Edward Pesicka - Director Peer Information Fortrea Holdings Inc. (CORR.) Fortrea Holdings Inc. (RSPI) Fortrea Holdings Inc. (CGXP) Fortrea Holdings Inc. (BGEN) Fortrea Holdings Inc. (GTBP) Fortrea Holdings Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 34965K107 SIC: 8071 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 02/26/26 Share - Related Items Shares Outstanding: 92.40 Most Recent Split Date: (:1) Beta: 1.59 Market Capitalization: $904.60 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.13 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.76 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 45.12% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 02/26/26

• Fundamental Ratios P/E Current FY Estimate: 12.88 Trailing 12 Months: 19.20 PEG Ratio: 0.29 Price Ratios Price/Book: 1.53 Price/Cash Flow: 6.23 Price / Sales: 0.33 EPS Growth vs. Year Ago Period: -47.83% vs. Previous Quarter: -36.84% Sales Growth vs. Year Ago Period: 3.91% vs. Previous Quarter: -1.27% ROE 12/31/25 - - 09/30/25 - 5.64 06/30/25 - 5.25 ROA 12/31/25 - - 09/30/25 - 1.56 06/30/25 - 1.72 Current Ratio 12/31/25 - - 09/30/25 - 1.00 06/30/25 - 1.02 Quick Ratio 12/31/25 - - 09/30/25 - 1.00 06/30/25 - 1.02 Operating Margin 12/31/25 - - 09/30/25 - 1.73 06/30/25 - 2.08 Net Margin 12/31/25 - - 09/30/25 - -36.77 06/30/25 - -37.57 Pre-Tax Margin 12/31/25 - - 09/30/25 - -37.04 06/30/25 - -37.66 Book Value 12/31/25 - - 09/30/25 - 6.40 06/30/25 - 6.51 Inventory Turnover 12/31/25 - - 09/30/25 - - 06/30/25 - - Debt-to-Equity 12/31/25 - - 09/30/25 - 1.81 06/30/25 - 1.87 Debt-to-Capital 12/31/25 - - 09/30/25 - 64.43 06/30/25 - 65.14

Powered by Zacks Investment Research ©